<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35745001</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3878</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules27123878</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a severe adult motor neuron disease that causes progressive neuromuscular atrophy, muscle wasting, weakness, and depressive-like symptoms. Our previous research suggests that mercury levels are directly associated with ALS progression. MeHg+-induced ALS is characterised by oligodendrocyte destruction, myelin basic protein (MBP) depletion, and white matter degeneration, leading to demyelination and motor neuron death. The selection of MeHg+ as a potential neurotoxicant is based on our evidence that it has been connected to the development of ALS-like characteristics. It causes glutamate-mediated excitotoxicity, calcium-dependent neurotoxicity, and an ALS-like phenotype. Dysregulation of IGF-1/GLP-1 signalling has been associated with ALS progression. The bioactive amino acid 4-hydroxyisoleucine (HI) from Trigonella foenum graecum acts as an insulin mimic in rodents and increases insulin sensitivity. This study examined the neuroprotective effects of 4-HI on MeHg+-treated adult Wistar rats with ALS-like symptoms, emphasising brain IGF1/GLP-1 activation. Furthermore, we investigated the effect of 4-HI on MBP levels in rat brain homogenate, cerebrospinal fluid (CSF), blood plasma, and cell death indicators such as caspase-3, Bax, and Bcl-2. Rats were assessed for muscular strength, locomotor deficits, depressed behaviour, and spatial learning in the Morris water maze (MWM) to measure neurobehavioral abnormalities. Doses of 4-HI were given orally for 42 days in the MeHg+ rat model at 50 mg/kg or 100 mg/kg to ameliorate ALS-like neurological dysfunctions. Additionally, neurotransmitters and oxidative stress markers were examined in rat brain homogenates. Our findings suggest that 4-HI has neuroprotective benefits in reducing MeHg+-induced behavioural, neurochemical, and histopathological abnormalities in ALS-like rats exposed to methylmercury.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shandilya</LastName><ForeName>Ambika</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2699-5512</Identifier><AffiliationInfo><Affiliation>Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehan</LastName><ForeName>Sidharth</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0034-835X</Identifier><AffiliationInfo><Affiliation>Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Sumit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sethi</LastName><ForeName>Pranshul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narula</LastName><ForeName>Acharan S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Narula Research, LLC, 107 Boulder Bluff, Chapel Hill, NC 27516, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Abdulrahman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Post Box 2455, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharbi</LastName><ForeName>Metab</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Post Box 2455, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alasmari</LastName><ForeName>Abdullah F</ForeName><Initials>AF</Initials><Identifier Source="ORCID">0000-0001-7569-4287</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Post Box 2455, Riyadh 11451, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ISFCP/IAEC/CPCSEA/Meeting No.28/2020/Protocol No.455</GrantID><Agency>Indo Soviet Friendship College of Pharmacy</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C104672">4-hydroxyisoleucine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008767">Methylmercury Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>04Y7590D77</RegistryNumber><NameOfSubstance UI="D007532">Isoleucine</NameOfSubstance></Chemical><Chemical><RegistryNumber>67763-96-6</RegistryNumber><NameOfSubstance UI="D007334">Insulin-Like Growth Factor I</NameOfSubstance></Chemical><Chemical><RegistryNumber>89750-14-1</RegistryNumber><NameOfSubstance UI="D052216">Glucagon-Like Peptide 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052216" MajorTopicYN="N">Glucagon-Like Peptide 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007334" MajorTopicYN="N">Insulin-Like Growth Factor I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007532" MajorTopicYN="N">Isoleucine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008767" MajorTopicYN="Y">Methylmercury Compounds</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">4-hydroxyisoleucine</Keyword><Keyword MajorTopicYN="N">GLP-1</Keyword><Keyword MajorTopicYN="N">IGF-1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">demyelination</Keyword><Keyword MajorTopicYN="N">methylmercury</Keyword><Keyword MajorTopicYN="N">motor neuron death</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35745001</ArticleId><ArticleId IdType="pmc">PMC9228431</ArticleId><ArticleId IdType="doi">10.3390/molecules27123878</ArticleId><ArticleId IdType="pii">molecules27123878</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alam M.M., Minj E., Yadav R.K., Mehan S. Neuroprotective potential of adenyl cyclase/cAMP/CREB and mitochondrial CoQ10 activator in amyotrophic lateral sclerosis rats. Curr. Bioact. Compd. 2021;17:53&#x2013;69. doi: 10.2174/1573407216999200723113054.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573407216999200723113054</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia R., Liu Y., Yang L., Gal J., Zhu H., Jia J. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS. Mol. Neurodegener. 2012;7:10. doi: 10.1186/1750-1326-7-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-10</ArticleId><ArticleId IdType="pmc">PMC3325858</ArticleId><ArticleId IdType="pubmed">22443542</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Mazzini L., Mora G. Disease-modifying therapies in amyotrophic lateral sclerosis. Neuropharmacology. 2020;167:107986. doi: 10.1016/j.neuropharm.2020.107986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2020.107986</ArticleId><ArticleId IdType="pubmed">32062193</ArticleId></ArticleIdList></Reference><Reference><Citation>Minj E., Upadhayay S., Mehan S. Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS. Neurochem. Res. 2021;46:2867&#x2013;2884. doi: 10.1007/s11064-021-03366-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-021-03366-2</ArticleId><ArticleId IdType="pubmed">34075522</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Wang S., Wang Y., Lu A., Hu C., Yan C. DHA ameliorates MeHg-induced PC12 cell apoptosis by inhibiting the ROS/JNK signaling pathway. Mol. Med. Rep. 2021;24:558. doi: 10.3892/mmr.2021.12197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.12197</ArticleId><ArticleId IdType="pmc">PMC8188641</ArticleId><ArticleId IdType="pubmed">34109428</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittencourt L.O., Dionizio A., Nascimento P.C., Puty B., Le&#xe3;o L.K., Luz D.A., Silva M.C., Amado L.L., Leite A., Buzalaf M.R., et al. Proteomic approach underlying the hippocampal neurodegeneration caused by low doses of methylmercury after long-term exposure in adult rats. Metallomics. 2019;11:390&#x2013;403. doi: 10.1039/C8MT00297E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8MT00297E</ArticleId><ArticleId IdType="pubmed">30525157</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeid E.H., Khalifa B.A., Said E.N., Arisha A.H., Reda R.M. Neurobehavioral and immune-toxic impairments induced by organic methyl mercury dietary exposure in Nile tilapia Oreochromis niloticus. Aquat. Toxicol. 2021;230:105702. doi: 10.1016/j.aquatox.2020.105702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aquatox.2020.105702</ArticleId><ArticleId IdType="pubmed">33264694</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassett T., Bach P., Chan H.M. Effects of methylmercury on the secretion of pro-inflammatory cytokines from primary microglial cells and astrocytes. Neurotoxicology. 2012;33:229&#x2013;234. doi: 10.1016/j.neuro.2011.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2011.10.003</ArticleId><ArticleId IdType="pubmed">22037494</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva Santana L.N., Bittencourt L.O., Nascimento P.C., Fernandes R.M., Teixeira F.B., Fernandes L.M., Silva M.C., Nogueira L.S., Amado L.L., Crespo-Lopez M.E., et al. Low doses of methylmercury exposure during adulthood in rats display oxidative stress, neurodegeneration in the motor cortex and lead to impairment of motor skills. J. Trace Elem. Med. Biol. 2019;51:19&#x2013;27. doi: 10.1016/j.jtemb.2018.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2018.09.004</ArticleId><ArticleId IdType="pubmed">30466930</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassil F., Fernagut P.O., Bezard E., Meissner W.G. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification? Prog. Neurobiol. 2014;118:1&#x2013;8. doi: 10.1016/j.pneurobio.2014.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2014.02.005</ArticleId><ArticleId IdType="pubmed">24582776</ArticleId></ArticleIdList></Reference><Reference><Citation>Huat T.J., Khan A.A., Pati S., Mustafa Z., Abdullah J.M., Jaafar H. IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells. BMC Neurosci. 2014;15:91. doi: 10.1186/1471-2202-15-91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-15-91</ArticleId><ArticleId IdType="pmc">PMC4117972</ArticleId><ArticleId IdType="pubmed">25047045</ArticleId></ArticleIdList></Reference><Reference><Citation>Supeno N.E., Pati S., Hadi R.A., Ghani A.R., Mustafa Z., Abdullah J.M., Idris F.M., Han X., Jaafar H. IGF-1 acts as controlling switch for long-term proliferation and maintenance of EGF/FGF-responsive striatal neural stem cells. Int. J. Med. Sci. 2013;10:522. doi: 10.7150/ijms.5325.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.5325</ArticleId><ArticleId IdType="pmc">PMC3607237</ArticleId><ArticleId IdType="pubmed">23532711</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Tweedie D., Mattson M.P., Holloway H.W., Greig N.H. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. J. Neurochem. 2010;113:1621&#x2013;1631. doi: 10.1111/j.1471-4159.2010.06731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06731.x</ArticleId><ArticleId IdType="pmc">PMC2912144</ArticleId><ArticleId IdType="pubmed">20374430</ArticleId></ArticleIdList></Reference><Reference><Citation>McMorris F.A., Smith T.M., DeSalvo S., Furlanetto R.W. Insulin-like growth factor I/somatomedin C: A potent inducer of oligodendrocyte development. Proc. Natl. Acad. Sci. USA. 1986;83:822&#x2013;826. doi: 10.1073/pnas.83.3.822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.83.3.822</ArticleId><ArticleId IdType="pmc">PMC322957</ArticleId><ArticleId IdType="pubmed">3511475</ArticleId></ArticleIdList></Reference><Reference><Citation>De Paula M.L., Cui Q.L., Hossain S., Antel J., Almazan G. The PTEN inhibitor bisperoxovanadium enhances myelination by amplifying IGF-1 signaling in rat and human oligodendrocyte progenitors. Glia. 2014;62:64&#x2013;77. doi: 10.1002/glia.22584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22584</ArticleId><ArticleId IdType="pubmed">24166839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi V.E., Locatelli V., Rizzi L. Neurotrophic and neuroregenerative effects of GH/IGF1. Int. J. Mol. Sci. 2017;18:2441. doi: 10.3390/ijms18112441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18112441</ArticleId><ArticleId IdType="pmc">PMC5713408</ArticleId><ArticleId IdType="pubmed">29149058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Est&#xe9;vez V., Defterali &#xc7;., Vicario-Abej&#xf3;n C. IGF-I: A key growth factor that regulates neurogenesis and synaptogenesis from embryonic to adult stages of the brain. Front. Neurosci. 2016;10:52. doi: 10.3389/fnins.2016.00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00052</ArticleId><ArticleId IdType="pmc">PMC4763060</ArticleId><ArticleId IdType="pubmed">26941597</ArticleId></ArticleIdList></Reference><Reference><Citation>Shandilya A., Mehan S. IGF-1/GLP-1 Signaling Activator 4-hydroxyisoleucine (4-HI) Prevent Neurobehavioral and Neurochemical Defects in Methylmercury-induced Experimental Model of ALS: Insights From CSF, Blood Plasma and Brain Homogenate Samples in Rats. Res. Sq. 2021 preprint.</Citation></Reference><Reference><Citation>Naia L., Ferreira I.L., Cunha-Oliveira T., Duarte A.I., Ribeiro M., Rosenstock T.R., La&#xe7;o M.N., Ribeiro M.J., Oliveira C.R., Saudou F., et al. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington&#x2019;s Disease human lymphoblasts. Mol. Neurobiol. 2015;51:331&#x2013;348. doi: 10.1007/s12035-014-8735-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8735-4</ArticleId><ArticleId IdType="pubmed">24841383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Huang L., Zhang M., Sun S., Wu Y. Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta. Toxicology. 2010;271:5&#x2013;12. doi: 10.1016/j.tox.2010.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2010.01.001</ArticleId><ArticleId IdType="pubmed">20064577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao S.Y. Rescue of &#x3b1;-synuclein cytotoxicity by insulin-like growth factors. Biochem. Biophys. Res. Commun. 2009;385:434&#x2013;438. doi: 10.1016/j.bbrc.2009.05.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.05.089</ArticleId><ArticleId IdType="pubmed">19470380</ArticleId></ArticleIdList></Reference><Reference><Citation>Carro E., Trejo J.L., Gerber A., Loetscher H., Torrado J., Metzger F., Torres-Aleman I. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol. Aging. 2006;27:1250&#x2013;1257. doi: 10.1016/j.neurobiolaging.2005.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2005.06.015</ArticleId><ArticleId IdType="pubmed">16183170</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.E., Dantzer R., Kelley K.W., McCusker R.H. Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice. J. Neuroinflammation. 2011;8:12. doi: 10.1186/1742-2094-8-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-12</ArticleId><ArticleId IdType="pmc">PMC3045937</ArticleId><ArticleId IdType="pubmed">21306618</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Z., Sun Z., Huang J., Hu Y., Wu Z., Mei B. Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-&#x3b2; peptide (1&#x2013;42) Neurosci. Lett. 2008;444:217&#x2013;221. doi: 10.1016/j.neulet.2008.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2008.08.047</ArticleId><ArticleId IdType="pubmed">18760331</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkavyi A., Abuirmeileh A., Lever R., Kingsbury A.E., Biggs C.S., Whitton P.S. Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson&#x2019;s disease. J. Neuroinflammation. 2008;5:19. doi: 10.1186/1742-2094-5-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-5-19</ArticleId><ArticleId IdType="pmc">PMC2426681</ArticleId><ArticleId IdType="pubmed">18492290</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry T., Haughey N.J., Mattson M.P., Egan J.M., Greig N.H. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J. Pharmacol. Exp. Ther. 2002;302:881&#x2013;888. doi: 10.1124/jpet.102.037481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.102.037481</ArticleId><ArticleId IdType="pubmed">12183643</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsarathy V., Holscher C. The novel GLP1 analogue, liraglutide, reduces inflammation in a mouse model of brain tissue injury; Proceedings of the Society for Neuroscience Annual Meeting; Washington, DC, USA. 12&#x2013;16 November 2011.</Citation></Reference><Reference><Citation>Yoon G., Kim Y.K., Song J. Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure. Pharmacol. Res. 2020;152:104615. doi: 10.1016/j.phrs.2019.104615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.104615</ArticleId><ArticleId IdType="pubmed">31881271</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera R., Mehan S., Bhalla S., Kumar S., Alshammari A., Alharbi M., Sadhu S.S. Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism. Molecules. 2022;27:889. doi: 10.3390/molecules27030889.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27030889</ArticleId><ArticleId IdType="pmc">PMC8839522</ArticleId><ArticleId IdType="pubmed">35164154</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Duffy K.B., Ottinger M.A., Ray B., Bailey J.A., Holloway H.W., Tweedie D., Perry T., Mattson M.P., Kapogiannis D., et al. GLP-1 receptor stimulation reduces amyloid-&#x3b2; peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer&#x2019;s disease. J. Alzheimers Dis. 2010;19:1205&#x2013;1219. doi: 10.3233/JAD-2010-1314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-1314</ArticleId><ArticleId IdType="pmc">PMC2948479</ArticleId><ArticleId IdType="pubmed">20308787</ArticleId></ArticleIdList></Reference><Reference><Citation>Bomfim T.R., Forny-Germano L., Sathler L.B., Brito-Moreira J., Houzel J.C., Decker H., Silverman M.A., Kazi H., Melo H.M., McClean P.L., et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer&#x2019;s disease&#x2013;associated A&#x3b2; oligomers. J. Clin. Investig. 2012;122:1339&#x2013;1353. doi: 10.1172/JCI57256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57256</ArticleId><ArticleId IdType="pmc">PMC3314445</ArticleId><ArticleId IdType="pubmed">22476196</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafar M.I., Gao F. 4-Hydroxyisoleucine: A potential new treatment for type 2 diabetes mellitus. BioDrugs. 2016;30:255&#x2013;262. doi: 10.1007/s40259-016-0177-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40259-016-0177-2</ArticleId><ArticleId IdType="pubmed">27151154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Ma J., Li Z., Liang Y., Xu Q., Xie X., Chen N. A strategy for L-isoleucine dioxygenase screening and 4-hydroxyisoleucine production by resting cells. Bioengineered. 2018;9:72&#x2013;79. doi: 10.1080/21655979.2017.1304872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21655979.2017.1304872</ArticleId><ArticleId IdType="pmc">PMC5972919</ArticleId><ArticleId IdType="pubmed">28430004</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurya C.K., Singh R., Jaiswal N., Venkateswarlu K., Narender T., Tamrakar A.K. 4-Hydroxyisoleucine ameliorates fatty acid-induced insulin resistance and inflammatory response in skeletal muscle cells. Mol. Cell. Endocrinol. 2014;395:51&#x2013;60. doi: 10.1016/j.mce.2014.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2014.07.018</ArticleId><ArticleId IdType="pubmed">25109277</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal N., Maurya C.K., Venkateswarlu K., Sukanya P., Srivastava A.K., Narender T., Tamrakar A.K. 4-Hydroxyisoleucine stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells via phosphatidylinositol-3-kinase-dependent pathway. Eur. J. Nutr. 2012;51:893&#x2013;898. doi: 10.1007/s00394-012-0374-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-012-0374-9</ArticleId><ArticleId IdType="pubmed">22610671</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeri M.R., Izaddoost M., Ardekani M.R., Nobar M.R., White K.N. The effect of fenugreek 4-hydroxyisoleucine on liver function biomarkers and glucose in diabetic and fructose-fed rats. Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2009;23:61&#x2013;64. doi: 10.1002/ptr.2557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.2557</ArticleId><ArticleId IdType="pubmed">18680121</ArticleId></ArticleIdList></Reference><Reference><Citation>Narender T., Puri A., Khaliq T., Saxena R., Bhatia G., Chandra R. 4-Hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent. Bioorganic Med. Chem. Lett. 2006;16:293&#x2013;296. doi: 10.1016/j.bmcl.2005.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2005.10.003</ArticleId><ArticleId IdType="pubmed">16246556</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayawan R., Kaur S. Studies on the effects of 4-hydroxy isoleucine in experimentally induced inflammatory bowel disease. Int. J. Pharm. Res. 2016;6:179&#x2013;188.</Citation></Reference><Reference><Citation>Zhou C., Chen R., Gao F., Zhang J., Lu F. 4-Hydroxyisoleucine relieves inflammation through iRhom2-dependent pathway in co-cultured macrophages and adipocytes with LPS stimulation. BMC Complementary Med. Ther. 2020;20:373. doi: 10.1186/s12906-020-03166-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-020-03166-1</ArticleId><ArticleId IdType="pmc">PMC7724822</ArticleId><ArticleId IdType="pubmed">33298044</ArticleId></ArticleIdList></Reference><Reference><Citation>Avalos-Soriano A., la Cruz-Cordero D., Rosado J.L., Garcia-Gasca T. 4-Hydroxyisoleucine from fenugreek (Trigonella foenum-graecum): Effects on insulin resistance associated with obesity. Molecules. 2016;21:1596. doi: 10.3390/molecules21111596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules21111596</ArticleId><ArticleId IdType="pmc">PMC6273931</ArticleId><ArticleId IdType="pubmed">27879673</ArticleId></ArticleIdList></Reference><Reference><Citation>Broca C., Breil V., Cruciani-Guglielmacci C., Manteghetti M., Rouault C., Derouet M., Rizkalla S., Pau B., Petit P., Ribes G., et al. Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. Am. J. Physiol. Endocrinol. Metab. 2004;287:E463&#x2013;E471. doi: 10.1152/ajpendo.00163.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00163.2003</ArticleId><ArticleId IdType="pubmed">15082420</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui E.M., Mehan S., Upadhayay S., Khan A., Halawi M., Halawi A.A., Alsaffar R.M. Neuroprotective efficacy of 4-Hydroxyisoleucine in experimentally induced intracerebral hemorrhage. Saudi J. Biol. Sci. 2021;28:6417&#x2013;6431. doi: 10.1016/j.sjbs.2021.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2021.07.010</ArticleId><ArticleId IdType="pmc">PMC8568986</ArticleId><ArticleId IdType="pubmed">34764759</ArticleId></ArticleIdList></Reference><Reference><Citation>Assad T., Siddiqui N., Rajput M.A., Sayyar H.T., Soban M., Hameed T. Assessment of antidepressant activity of fenugreek seeds methanol extract. Rawal Med. J. 2021;46:236&#x2013;239.</Citation></Reference><Reference><Citation>Kalshetti P.B., Alluri R., Mohan V., Thakurdesai P.A. Effects of 4-hydroxyisoleucine from fenugreek seeds on depression-like behavior in socially isolated olfactory bulbectomized rats. Pharmacogn. Mag. 2015;11:S388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4745208</ArticleId><ArticleId IdType="pubmed">26929572</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaur V., Bodhankar S.L., Mohan V., Thakurdesai P. Antidepressant-like effect of 4-hydroxyisoleucine from Trigonella foenum graecum L. seeds in mice. Biomed. Aging Pathol. 2012;2:121&#x2013;125. doi: 10.1016/j.biomag.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomag.2012.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Morani A.S., Bodhankar S.L., Mohan V., Thakurdesai P.A. Ameliorative effects of standardized extract from Trigonella foenum&#x2013;graecum L. seeds on painful peripheral neuropathy in rats. Asian Pac. J. Trop. Med. 2012;5:385&#x2013;390. doi: 10.1016/S1995-7645(12)60064-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1995-7645(12)60064-9</ArticleId><ArticleId IdType="pubmed">22546656</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadaun K.S., Mehan S., Sharma A., Siddiqui E.M., Kumar S., Alsuhaymi N. Neuroprotective Effect of Chrysophanol as a PI3K/AKT/mTOR Signaling Inhibitor in an Experimental Model of Autologous Blood-induced Intracerebral Hemorrhage. Curr. Med. Sci. 2022 doi: 10.1007/s11596-022-2496-x. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11596-022-2496-x</ArticleId><ArticleId IdType="pubmed">35099677</ArticleId></ArticleIdList></Reference><Reference><Citation>King K., Lin N.P., Cheng Y.H., Chen G.H., Chein R.J. Isolation of positive modulator of glucagon-like peptide-1 signaling from Trigonella foenum-graecum (fenugreek) seed. J. Biol. Chem. 2015;290:26235&#x2013;26248. doi: 10.1074/jbc.M115.672097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.672097</ArticleId><ArticleId IdType="pmc">PMC4646272</ArticleId><ArticleId IdType="pubmed">26336108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam S., Ishrat N., Yadav P., Singh R., Narender T., Srivastava A.K. 4-Hydroxyisoleucine attenuates the inflammation-mediated insulin resistance by the activation of AMPK and suppression of SOCS-3 coimmunoprecipitation with both the IR-&#x3b2; subunit as well as IRS-1. Mol. Cell. Biochem. 2016;414:95&#x2013;104. doi: 10.1007/s11010-016-2662-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-016-2662-9</ArticleId><ArticleId IdType="pubmed">26887316</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma L., Sakir M., Singh N., Mehra R., Mehan S. Development of phase change solutions for ophthalmic drug delivery based on ion activated and pH induced polymers. Int. J. Pharm. Prof. Res. 2010;1:127&#x2013;134.</Citation></Reference><Reference><Citation>Rajdev K., Siddiqui E.M., Jadaun K.S., Mehan S. Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats. IBRO Rep. 2020;8:101&#x2013;114. doi: 10.1016/j.ibror.2020.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ibror.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7184235</ArticleId><ArticleId IdType="pubmed">32368686</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Mehan S. PI3K/AKT/mTOR Signalling Inhibitor Chrysophanol Ameliorates Neurobehavioural and Neurochemical Defects in Propionic Acid-induced Experimental Model of Autism. Metab. Brain Dis. 2022 doi: 10.1007/s11011-022-01026-0. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-022-01026-0</ArticleId><ArticleId IdType="pubmed">35687217</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehan S., Rahi S., Tiwari A., Kapoor T., Rajdev K., Sharma R., Khera H., Kosey S., Kukkar U., Dudi R. Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats. Neural Regen. Res. 2020;15:1140. doi: 10.4103/1673-5374.270316.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.270316</ArticleId><ArticleId IdType="pmc">PMC7034277</ArticleId><ArticleId IdType="pubmed">31823895</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R., Rahi S., Mehan S. Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: Insights from behavioral and biochemical evidence. Toxicol. Rep. 2019;6:1164&#x2013;1175. doi: 10.1016/j.toxrep.2019.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxrep.2019.10.019</ArticleId><ArticleId IdType="pmc">PMC6861559</ArticleId><ArticleId IdType="pubmed">31763180</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggal P., Jadaun K.S., Siqqiqui E.M., Mehan S. Investigation of low dose cabazitaxel potential as microtubule stabilizer in experimental model of Alzheimer&#x2019;s disease: Restoring neuronal cytoskeleton. Curr. Alzheimer Res. 2020;17:601&#x2013;615. doi: 10.2174/1567205017666201007120112.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205017666201007120112</ArticleId><ArticleId IdType="pubmed">33030130</ArticleId></ArticleIdList></Reference><Reference><Citation>Boynton F.D., Dunbar M., Koewler N. The Laboratory Rat. Academic Press; Cambridge, MA, USA: 2020. General experimental techniques; pp. 771&#x2013;809.</Citation></Reference><Reference><Citation>Gupta R., Mehan S., Sethi P., Prajapati A., Alshammari A., Alharbi M., Al-Mazroua H.A., Narula A.S. Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder. Brain Sci. 2022;12:342. doi: 10.3390/brainsci12030342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12030342</ArticleId><ArticleId IdType="pmc">PMC8946713</ArticleId><ArticleId IdType="pubmed">35326298</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu R., Mehan S., Kumar S., Prajapati A., Alshammari A., Alharbi M., Assiri M.A., Narula A.S. Effect of alpha-mangostin in the prevention of behavioral and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats. Toxicol. Rep. 2022;9:977&#x2013;998. doi: 10.1016/j.toxrep.2022.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxrep.2022.04.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Ola M.S., Aleisa A.M., Al-Rejaie S.S., Abuohashish H.M., Parmar M.Y., Alhomida A.S., Ahmed M.M. Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats. Neurol. Sci. 2014;35:1003&#x2013;1008. doi: 10.1007/s10072-014-1628-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-014-1628-5</ArticleId><ArticleId IdType="pubmed">24413816</ArticleId></ArticleIdList></Reference><Reference><Citation>Candeias E., Sebasti&#xe3;o I., Cardoso S., Carvalho C., Santos M.S., Oliveira C.R., Moreira P.I., Duarte A.I. Brain GLP-1/IGF-1 signaling and autophagy mediate exendin-4 protection against apoptosis in type 2 diabetic rats. Mol. Neurobiol. 2018;55:4030&#x2013;4050. doi: 10.1007/s12035-017-0622-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0622-3</ArticleId><ArticleId IdType="pubmed">28573460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta M., Ohta K., Nishimura M., Saida T. Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Ann. Clin. Biochem. 2002;39:603&#x2013;605. doi: 10.1177/000456320203900610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000456320203900610</ArticleId><ArticleId IdType="pubmed">12564844</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi Z., Mashayekhi F., Naji M. Insulin like growth factor-1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer&#x2019;s disease. Biofactors. 2008;33:99&#x2013;106. doi: 10.1002/biof.5520330202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.5520330202</ArticleId><ArticleId IdType="pubmed">19346585</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahi S., Gupta R., Sharma A., Mehan S. Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism. Hum. Exp. Toxicol. 2021;40:1880&#x2013;1898. doi: 10.1177/09603271211013456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09603271211013456</ArticleId><ArticleId IdType="pubmed">33906504</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav R.K., Mehan S., Sahu R., Kumar S., Khan A., Makeen H.A., Al Bratty M. Protective effects of apigenin on methylmercury-induced behavioral/neurochemical abnormalities and neurotoxicity in rats. Hum. Exp. Toxicol. 2022;41:09603271221084276. doi: 10.1177/09603271221084276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09603271221084276</ArticleId><ArticleId IdType="pubmed">35373622</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A., Khera R., Rahi S., Mehan S., Makeen H.A., Khormi Y.H., Rehman M.U., Khan A. Neuroprotective Effect of &#x3b1;-Mangostin in Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats. Brain Sci. 2021;11:288. doi: 10.3390/brainsci11030288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030288</ArticleId><ArticleId IdType="pmc">PMC7996534</ArticleId><ArticleId IdType="pubmed">33669120</ArticleId></ArticleIdList></Reference><Reference><Citation>Budworth H., Snijders A.M., Marchetti F., Mannion B., Bhatnagar S., Kwoh E., Tan Y., Wang S.X., Blakely W.F., Coleman M., et al. DNA repair and cell cycle biomarkers of radiation exposure and inflammation stress in human blood. PLoS ONE. 2012;7:e48619. doi: 10.1371/journal.pone.0048619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048619</ArticleId><ArticleId IdType="pmc">PMC3492462</ArticleId><ArticleId IdType="pubmed">23144912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N., Upadhayay S., Shandilya A., Sahu R., Singh A., Rajkhowa B., Mehan S. Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats. Phytomedicine Plus. 2021;1:100051. doi: 10.1016/j.phyplu.2021.100051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phyplu.2021.100051</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao S.S., Lu M.M., Leng R.X., Pan H.F., Ye D.Q. Expression level of plasma Bcl-xL and Bcl-2 in patients with systemic lupus erythematosus. Int. J. Clin. Exp. Med. 2016;9:6801&#x2013;6806.</Citation></Reference><Reference><Citation>Alam M., Yadav R.K., Minj E., Tiwari A., Mehan S. Exploring molecular approaches in Amyotrophic lateral sclerosis: Drug targets from clinical and pre-clinical findings. Curr. Mol. Pharmacol. 2021;14:263&#x2013;280. doi: 10.2174/1566524020666200427214356.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524020666200427214356</ArticleId><ArticleId IdType="pubmed">32342825</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehan S., Monga V., Rani M., Dudi R., Ghimire K. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington&#x2019;s disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction. Indian J. Pharmacol. 2018;50:309. doi: 10.4103/ijp.IJP_11_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijp.IJP_11_18</ArticleId><ArticleId IdType="pmc">PMC6364342</ArticleId><ArticleId IdType="pubmed">30783323</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera H., Awasthi A., Mehan S. Myocardial preconditioning potential of hedgehog activator purmorphamine (smoothened receptor agonist) against ischemia-reperfusion in deoxycortisone acetate salt-induced hypertensive rat hearts. J. Pharmacol. Pharmacother. 2019;10:47. doi: 10.4103/jpp.JPP_8_19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jpp.JPP_8_19</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu N., Shen H., Liu H., Wang Y., Bai Y., Han P. Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo. Cardiovasc. Diabetol. 2016;15:109. doi: 10.1186/s12933-016-0427-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-016-0427-0</ArticleId><ArticleId IdType="pmc">PMC4974767</ArticleId><ArticleId IdType="pubmed">27496150</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Wang W., Ding H., Yang Q., Dong Q., Cui M. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia. J. Neuroinflammation. 2016;13:204. doi: 10.1186/s12974-016-0661-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0661-0</ArticleId><ArticleId IdType="pmc">PMC5002167</ArticleId><ArticleId IdType="pubmed">27566245</ArticleId></ArticleIdList></Reference><Reference><Citation>Speaker K.J., Cox S.S., Paton M.M., Serebrakian A., Maslanik T., Greenwood B.N., Fleshner M. Six weeks of voluntary wheel running modulates inflammatory protein (MCP-1, IL-6, and IL-10) and DAMP (Hsp72) responses to acute stress in white adipose tissue of lean rats. Brain Behav. Immun. 2014;39:87&#x2013;98. doi: 10.1016/j.bbi.2013.10.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2013.10.028</ArticleId><ArticleId IdType="pmc">PMC4301739</ArticleId><ArticleId IdType="pubmed">24246250</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehan S., Parveen S., Kalra S. Adenyl cyclase activator forskolin protects against Huntington&#x2019;s disease-like neurodegenerative disorders. Neural Regen. Res. 2017;12:290. doi: 10.4103/1673-5374.200812.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.200812</ArticleId><ArticleId IdType="pmc">PMC5361515</ArticleId><ArticleId IdType="pubmed">28400813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur R., Mehan S., Khanna D., Kalra S. Polyphenol Ellagic Acid&#x2013;Targeting to Brain: A Hidden Treasure. Int. J. Neurol. Res. 2015;1:141&#x2013;152.</Citation></Reference><Reference><Citation>Dudi R., Mehan S. Neuroprotection of brain permeable Forskolin ameliorates behavioral, biochemical and histopatho-logical alterations in rat model of intracerebral hemorrhage. Pharmaspire. 2018;10:68&#x2013;86.</Citation></Reference><Reference><Citation>Singh L., Rana S., Mehan S. Role of adenylyl cyclase activator in controlling experimental diabetic nephropathy in rats. Int. J. Physiol. Pathophysiol. Pharmacol. 2018;10:144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6261921</ArticleId><ArticleId IdType="pubmed">30515257</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh R., Sharma V., Mehan S., Sharma N., Bedi K.L. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine&#x2014;A PDE1 inhibitor. Eur. J. Pharmacol. 2009;620:49&#x2013;56. doi: 10.1016/j.ejphar.2009.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2009.08.027</ArticleId><ArticleId IdType="pubmed">19699735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bala R., Khanna D., Mehan S., Kalra S. Experimental evidence for the potential of lycopene in the management of scopolamine induced amnesia. RSC Adv. 2015;5:72881&#x2013;72892. doi: 10.1039/C5RA13160J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5RA13160J</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N., Sharma N., Khera R., Gupta R., Mehan S. Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain. Metab. Brain Dis. 2021;36:911&#x2013;925. doi: 10.1007/s11011-021-00691-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-021-00691-x</ArticleId><ArticleId IdType="pubmed">33635478</ArticleId></ArticleIdList></Reference><Reference><Citation>Praline J., Guennoc A.M., Limousin N., Hallak H., de Toffol B., Corcia P. ALS and mercury intoxication: A relationship? Clin. Neurol. Neurosurg. 2007;109:880&#x2013;883. doi: 10.1016/j.clineuro.2007.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2007.07.008</ArticleId><ArticleId IdType="pubmed">17719172</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson F.O., Atchison W.D. The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology. 2009;30:761&#x2013;765. doi: 10.1016/j.neuro.2009.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2009.07.010</ArticleId><ArticleId IdType="pmc">PMC2761528</ArticleId><ArticleId IdType="pubmed">19632272</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.A. Ph.D. Thesis. University of Manitoba; Winnipeg, MB, Canada: 2011. Metallomics of Mercury: The Role of Selenium.</Citation></Reference><Reference><Citation>Farina M., Rocha J.B., Aschner M. Mechanisms of methylmercury-induced neurotoxicity: Evidence from experimental studies. Life Sci. 2011;89:555&#x2013;563. doi: 10.1016/j.lfs.2011.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2011.05.019</ArticleId><ArticleId IdType="pmc">PMC3183295</ArticleId><ArticleId IdType="pubmed">21683713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori N., Yasutake A., Marumoto M., Hirayama K. Methylmercury inhibits electron transport chain activity and induces cytochrome c release in cerebellum mitochondria. J. Toxicol. Sci. 2011;36:253&#x2013;259. doi: 10.2131/jts.36.253.</Citation><ArticleIdList><ArticleId IdType="doi">10.2131/jts.36.253</ArticleId><ArticleId IdType="pubmed">21628953</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos A.A., Hort M.A., Culbreth M., L&#xf3;pez-Granero C., Farina M., Rocha J.B., Aschner M. Methylmercury and brain development: A review of recent literature. J. Trace Elem. Med. Biol. 2016;38:99&#x2013;107. doi: 10.1016/j.jtemb.2016.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2016.03.001</ArticleId><ArticleId IdType="pmc">PMC5011031</ArticleId><ArticleId IdType="pubmed">26987277</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukhanov S., Higashi Y., Shai S.Y., Vaughn C., Mohler J., Li Y., Song Y.H., Titterington J., Delafontaine P. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2007;27:2684&#x2013;2690. doi: 10.1161/ATVBAHA.107.156257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.107.156257</ArticleId><ArticleId IdType="pubmed">17916769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesik D., De Keyser J., Wilczak N. Insulin-like growth factor system regulates oligodendroglial cell behavior: Therapeutic potential in CNS. J. Mol. Neurosci. 2008;35:81&#x2013;90. doi: 10.1007/s12031-008-9041-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-008-9041-2</ArticleId><ArticleId IdType="pubmed">18299999</ArticleId></ArticleIdList></Reference><Reference><Citation>Freude S., Leeser U., M&#xfc;ller M., Hettich M.M., Udelhoven M., Schilbach K., Tobe K., Kadowaki T., K&#xf6;hler C., Schr&#xf6;der H., et al. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination. J. Neurochem. 2008;107:907&#x2013;917. doi: 10.1111/j.1471-4159.2008.05631.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05631.x</ArticleId><ArticleId IdType="pubmed">18717815</ArticleId></ArticleIdList></Reference><Reference><Citation>Shandilya A., Mehan S. Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: Potential target activators and influences on neurological dysfunctions. Neurol. Sci. 2021;42:3145&#x2013;3166. doi: 10.1007/s10072-021-05328-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05328-6</ArticleId><ArticleId IdType="pubmed">34018075</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczyk-Marc I., Wawrzyniak A., Luszczewska-Sierakowska I., Babicz M.A., Orkisz S.T. Oligodendrocytes: Morphology, functions and involvement in neurodegenerative diseases. Med. Weter. 2019;75:465&#x2013;471. doi: 10.21521/mw.6258.</Citation><ArticleIdList><ArticleId IdType="doi">10.21521/mw.6258</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields R.D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 2008;31:361&#x2013;370. doi: 10.1016/j.tins.2008.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2008.04.001</ArticleId><ArticleId IdType="pmc">PMC2486416</ArticleId><ArticleId IdType="pubmed">18538868</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Pagani M., Agosta F., Calvo A., Cistaro A., Filippi M. Neuroimaging in amyotrophic lateral sclerosis: Insights into structural and functional changes. Lancet Neurol. 2014;13:1228&#x2013;1240. doi: 10.1016/S1474-4422(14)70167-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70167-X</ArticleId><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S.H., Li Y., Fukaya M., Lorenzini I., Cleveland D.W., Ostrow L.W., Rothstein J.D., Bergles D.E. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 2013;16:571&#x2013;579. doi: 10.1038/nn.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3357</ArticleId><ArticleId IdType="pmc">PMC3637847</ArticleId><ArticleId IdType="pubmed">23542689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente Pons A., Higginbottom A., Cooper-Knock J., Alrafiah A., Alofi E., Kirby J., Shaw P.J., Wood J.D., Highley J.R. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. J. Pathol. 2020;251:262&#x2013;271. doi: 10.1002/path.5455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5455</ArticleId><ArticleId IdType="pubmed">32391572</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Qin Z.H. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis. 2010;15:1382&#x2013;1402. doi: 10.1007/s10495-010-0481-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-010-0481-0</ArticleId><ArticleId IdType="pubmed">20213199</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W., Ma Y., Guan F., Zhang X., Chen W., Zhang L., Zhang L. Ablation of C9orf72 together with excitotoxicity induces ALS in rats. FEBS J. 2021;288:1712&#x2013;1723. doi: 10.1111/febs.15501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15501</ArticleId><ArticleId IdType="pubmed">32745320</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali A., Kang Y.S. Transport alteration of 4-phenyl butyric acid mediated by a sodium-and proton-coupled monocarboxylic acid transporter system in ALS model cell lines (NSC-34) under inflammatory states. J. Pharm. Sci. 2021;110:1374&#x2013;1384. doi: 10.1016/j.xphs.2020.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xphs.2020.10.030</ArticleId><ArticleId IdType="pubmed">33098824</ArticleId></ArticleIdList></Reference><Reference><Citation>Park E., Velumian A.A., Fehlings M.G. The role of excitotoxicity in secondary mechanisms of spinal cord injury: A review with an emphasis on the implications for white matter degeneration. J. Neurotrauma. 2004;21:754&#x2013;774. doi: 10.1089/0897715041269641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/0897715041269641</ArticleId><ArticleId IdType="pubmed">15253803</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster B.R., Pomper M.G., Callaghan B.C., Petrou M., Edden R.A., Mohamed M.A., Welsh R.C., Carlos R.C., Barker P.B., Feldman E.L. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol. 2013;70:1009&#x2013;1016. doi: 10.1001/jamaneurol.2013.234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.234</ArticleId><ArticleId IdType="pmc">PMC4382938</ArticleId><ArticleId IdType="pubmed">23797905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.H., Allen K., Oei F., Leoni E., Kuhle J., Tree T., Fratta P., Sharma N., Sidle K., Howard R., et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 2016;3:e244. doi: 10.1212/NXI.0000000000000244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000244</ArticleId><ArticleId IdType="pmc">PMC4897985</ArticleId><ArticleId IdType="pubmed">27308305</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu G.N., Kumar A., Chandra R., Puri S.K., Kalita J., Misra U.K. Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India. Neurochem. Res. 2008;33:1145&#x2013;1149. doi: 10.1007/s11064-007-9564-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-007-9564-x</ArticleId><ArticleId IdType="pubmed">18246426</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai-Shimada M., Takahashi T., Kim M.S., Fujimura M., Ito H., Toyama T., Naganuma A., Hwang G.W. Methylmercury induces the expression of TNF-&#x3b1; selectively in the brain of mice. Sci. Rep. 2016;6:38294. doi: 10.1038/srep38294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep38294</ArticleId><ArticleId IdType="pmc">PMC5133575</ArticleId><ArticleId IdType="pubmed">27910896</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanker G., Aschner J.L., Syversen T., Aschner M. Free radical formation in cerebral cortical astrocytes in culture induced by methylmercury. Mol. Brain Res. 2004;128:48&#x2013;57. doi: 10.1016/j.molbrainres.2004.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molbrainres.2004.05.022</ArticleId><ArticleId IdType="pubmed">15337317</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangoumau A., Marouillat S., Coelho R., Wurmser F., Brulard C., Haouari S., Laumonnier F., Corcia P., Andres C.R., Blasco H., et al. Dysregulations of expression of genes of the ubiquitin/sumo pathways in an in vitro model of amyotrophic lateral sclerosis combining oxidative stress and sod1 gene mutation. Int. J. Mol. Sci. 2021;22:1796. doi: 10.3390/ijms22041796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041796</ArticleId><ArticleId IdType="pmc">PMC7918082</ArticleId><ArticleId IdType="pubmed">33670299</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X., Zhou J., Li Y., Wu K., Chen Z., Luo Z., Zhang X., Liang Y., Esteban M.A., Zhou Y., et al. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat. Struct. Mol. Biol. 2021;28:132&#x2013;142. doi: 10.1038/s41594-020-00537-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00537-7</ArticleId><ArticleId IdType="pubmed">33398173</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Schulte D.J., Ravits J. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol. Clin. 2015;33:855&#x2013;876. doi: 10.1016/j.ncl.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa D.M., Ceccarelli A., Dicuonzo F., Carella A., De Caro M.F., Lopez M., Samarelli V., Livrea P., Simone I.L. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. Am. J. Neuroradiol. 2007;28:255&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7977419</ArticleId><ArticleId IdType="pubmed">17296989</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S., Goldstein L.H., Suckling J., Ng V., Simmons A., Chitnis X., Atkins L., Williams S.C., Leigh P. Frontotemporal white matter changes in amyotrophic lateral sclerosis. J. Neurol. 2005;252:321&#x2013;331. doi: 10.1007/s00415-005-0646-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-005-0646-x</ArticleId><ArticleId IdType="pubmed">15739047</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>